These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34014611)

  • 1. Relationship between regional gray matter volumes and dopamine D
    Kurose S; Kubota M; Takahata K; Yamamoto Y; Fujiwara H; Kimura Y; Ito H; Takeuchi H; Mimura M; Suhara T; Higuchi M
    Hum Brain Mapp; 2021 Aug; 42(12):4048-4058. PubMed ID: 34014611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.
    Morales AM; Kohno M; Robertson CL; Dean AC; Mandelkern MA; London ED
    Mol Psychiatry; 2015 Jun; 20(6):764-71. PubMed ID: 25896164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between subcortical brain volume and striatal dopamine D
    Caravaggio F; Ku Chung J; Plitman E; Boileau I; Gerretsen P; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A
    Hum Brain Mapp; 2017 Nov; 38(11):5519-5534. PubMed ID: 28752565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [
    Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A
    Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs.
    Bang JI; Jung IS; Song YS; Park HS; Moon BS; Lee BC; Kim SE
    Nucl Med Biol; 2016 Feb; 43(2):158-64. PubMed ID: 26872440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D
    Khodaii J; Nomura Y; Chang NHS; Wong DF; Møller A; Gjedde A
    Neurochem Res; 2023 May; 48(5):1517-1530. PubMed ID: 36525123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study.
    Rogeau A; Nordio G; Veronese M; Brown K; Nour MM; Osugo M; Jauhar S; Howes OD; McCutcheon RA
    Mol Psychiatry; 2022 Aug; 27(8):3493-3500. PubMed ID: 35546633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults.
    Smith CT; San Juan MD; Dang LC; Katz DT; Perkins SF; Burgess LL; Cowan RL; Manning HC; Nickels ML; Claassen DO; Samanez-Larkin GR; Zald DH
    Transl Psychiatry; 2018 Dec; 8(1):269. PubMed ID: 30531858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.
    Smith CT; Dang LC; Buckholtz JW; Tetreault AM; Cowan RL; Kessler RM; Zald DH
    Transl Psychiatry; 2017 Apr; 7(4):e1091. PubMed ID: 28398340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [
    Jonasson M; Frick A; Fazio P; Hjorth O; Danfors T; Axelsson J; Appel L; Furmark T; Varrone A; Lubberink M
    J Cereb Blood Flow Metab; 2023 Jul; 43(7):1206-1215. PubMed ID: 36912083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
    Choi H; Cheon GJ; Kim HJ; Choi SH; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
    Hum Brain Mapp; 2016 May; 37(5):1710-21. PubMed ID: 26846350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain.
    Yamamoto Y; Takahata K; Kubota M; Takano H; Takeuchi H; Kimura Y; Sano Y; Kurose S; Ito H; Mimura M; Higuchi M
    Neuroimage; 2021 Feb; 226():117543. PubMed ID: 33186713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum.
    Martikainen IK; Nuechterlein EB; Peciña M; Love TM; Cummiford CM; Green CR; Stohler CS; Zubieta JK
    J Neurosci; 2015 Jul; 35(27):9957-65. PubMed ID: 26156996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification and discriminative power of
    Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.
    Volkow ND; Wang GJ; Logan J; Alexoff D; Fowler JS; Thanos PK; Wong C; Casado V; Ferre S; Tomasi D
    Transl Psychiatry; 2015 Apr; 5(4):e549. PubMed ID: 25871974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
    Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
    Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High long-term test-retest reliability for extrastriatal
    Karalija N; Jonassson L; Johansson J; Papenberg G; Salami A; Andersson M; Riklund K; Nyberg L; Boraxbekk CJ
    J Cereb Blood Flow Metab; 2020 Sep; 40(9):1859-1868. PubMed ID: 31506011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.